Semax for brain fog after NAD: what the research actually supports

A recent TikTok video features Lindsay Pittman discussing her decision to cycle off NAD and try Semax to continue addressing brain fog. The clip, captioned “Cycled off NAD & wanted to continue battling brain fog #semax #peptidetherapy,” implies that Semax may offer cognitive benefits that overlap with or extend those of NAD. But what does the research actually say?

What the clip claims

The clip presents Semax as a potential tool for managing brain fog, especially after stopping NAD. While it does not make explicit medical claims, the implication is that Semax could support mental clarity and cognitive function. This aligns with popular peptide discussions, but the evidence base is more nuanced.

What the research neighborhood covers

Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) and has been studied primarily in Russia and Eastern Europe. Preclinical and small human studies suggest potential nootropic effects, including improved attention, memory, and recovery from cognitive stress. However, most research is not recent, and large-scale, placebo-controlled trials are lacking. The mechanism is thought to involve modulation of brain-derived neurotrophic factor (BDNF) and dopamine/serotonin systems, which could theoretically support cognitive function.

NAD (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy and has been studied for its role in aging and cognitive decline. The transition from NAD to Semax is not directly supported by any comparative or sequential studies. Each peptide has distinct mechanisms, and there is no published evidence that Semax is a suitable “follow-up” to NAD for brain fog.

Limits of the evidence

Most Semax studies are small, short-term, and conducted in specific populations (e.g., stroke recovery, cognitive fatigue). The peptide is not approved by the FDA for any use, and its long-term safety profile is not well characterized. Brain fog is a subjective symptom with many potential causes, and no peptide has been proven to treat it universally. Individual responses may vary, and the clip does not mention dosing, cycle length, or potential side effects.

Research-use caveat

Semax is sold for research purposes only, not for human consumption. Any discussion of using it to manage brain fog is speculative and not supported by regulatory approvals. Researchers studying Semax should focus on its molecular mechanisms and potential applications in controlled settings, not as a consumer remedy.

Open the full video fact-check page (transcript, takeaways, embedded clip).